Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 1996

View Archived Issues

Kyorin claims cholinergic agents

Anti-H. pylori compounds from Fujisawa

Chugai describes agents that stimulate gastrointestinal motility

Otsuka discloses inhibitor of TNF-alpha production

Kissei begins overseas development of BPH treatment agent

Potent and selective PAF antagonist from Uriach

French market introduction for Epivir

Merck & Co. launches Hyzaar in France

Chiesi reports pharmacological profile of CHF-2363

New market introduction for dorzolamide

Spanish investigators discover novel antihypertensive agent

French market introduction for Fractal

New one-hour H. pylori diagnostic tool now available to Japanese health care specialists

Arris/Merck & Co. osteoporosis collaboration

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Solvay and TheraTech end HRT collaboration

Angiogenesis-inhibitory activity reported for spironolactone

Pharmagenesis and Lilly collaborate on development of antifungal agents

IVAX and Glaxo Wellcome to expand Easi-Breathe agreement

NIH to conduct clinical trial of Ampalex in AD

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Thalidomide clinical trials in brain cancer expanded

First filing for Imutec's Virulizin

Taxotere approved in three additional markets

First regulatory approval for impotence treatment

Approval recommended for Elan's gel formulation of diazepam

Company Profile: Megabios

Company Profile: Inex

Genetics Institute's factor IX scheduled for review

Antimalarial combination demonstrates excellent efficacy

Vion Pharmaceuticals expands pivotal trials of new cancer treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...